Patients Delivering for patients and sites in 2025 As I look at 2025, and try to see what will happen in the world of clinical trials, it is important to see the progress we have made.
Digital Transitioning PROs from paper to digital: Maintaining data i... Patient-reported outcomes (PROs) provide important insights for clinical trials.
News Perlmutter's Eikon follows the IPO trail Two more biotechs have joined the Nasdaq IPO queue, namely Roger Perlmutter's cancer biotech Eikon and hair loss drug developer Veradermics.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
